The US financial year is a calendar year.
In my line of work, any US business we deal with is desperate to book all budgeted work before December 31, hence probably why revenues get a boost in the December quarter.
The chart is range bound at the moment with some volume capping the low/high limits.
With Xenos's Kojent partner selling a large chunk I doubt they will want a large spike so soon after a large block sale.
Management have stated CY21 revenues of $59M-$60M, which suggests $19M for December. Anything above $20M will be a bonus.
Payments to supplier and employees was $19.1M for September, $17.5M in June and $18.2M in March.
If $20M revenue can be the baseline in 2022, then they have passed a significant hump.
- Forums
- ASX - By Stock
- MDR Charting
MDR
medadvisor limited
Add to My Watchlist
0.00%
!
8.0¢

The US financial year is a calendar year. In my line of work,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.98M |
Open | High | Low | Value | Volume |
8.0¢ | 8.1¢ | 8.0¢ | $39.78K | 497.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 370000 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.8¢ | 75865 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 370000 | 0.077 |
2 | 72644 | 0.076 |
1 | 46500 | 0.075 |
2 | 100013 | 0.074 |
1 | 200000 | 0.073 |
Price($) | Vol. | No. |
---|---|---|
0.088 | 75865 | 2 |
0.090 | 40000 | 1 |
0.091 | 100000 | 1 |
0.095 | 10588 | 1 |
0.099 | 26569 | 1 |
Last trade - 15.11pm 20/06/2025 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |